For information on the use of rapid antigen tests and what to do if you test positive, follow your local state or territory health advice: ACT, NSW, NT, QLD, SA, TAS, VIC, and WA.
Find information about the supply of COVID-19 rapid antigen self-tests to assist sponsors, manufacturers and consumers. Also includes information about the detection of multiple respiratory targets such as influenza A, influenza B and COVID-19 in a single rapid antigen test format (Combination RATs).
Information about the post-market review of all approved COVID-19 tests and a post-market evaluation of all approved serology-based COVID point-of-care tests.
The Therapeutic Goods Administration is part of the Health Products Regulation Group